Genentech, a member of the Roche Group, announced that the U.S Food And Drugs Administration accepted their product, Actemra,...

Roche, the pharmaceutical conglomerate, developed a new immunotherapy based on a new drug called Tecentriq. A group of researchers...

A week ago, Roche , announced that ACE910 experimental drug has received a breakthrough therapy designation from the United...